Aptamer Group is the developer of custom affinity tools for the life science industry through its proprietary Optimer® platform. Optimer binders are affinity ligands that can be used as an antibody alternative to offer novel solutions and improvements to current processes across therapeutic, diagnostic, and research sectors. Offering rapid development in just weeks, controlled and tuneable binding kinetics to ensure desired end-use performance, Optimer binders are engineered to remove barriers to innovation across the life sciences.
Aptamer Group is a developer of custom Optimer reagents as antibody mimetics for use as tool affinity reagents, in biomarker discovery, as diagnostic reagents and as therapeutic lead candidates.
